Thalidomide-5-NH2-C8-NH2 (TFA)

• UNSPSC Description:

  Thalidomide-5-NH2-C8-NH2 TFA can be used for compound synthesis[1].

• Target Antigen:

  Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates

• Type:

  Reference compound

• Related Pathways:

  Apoptosis;Autophagy;PROTAC

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/thalidomide-5-nh2-c8-nh2-tfa.html

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=C(C(F)(F)F)O.O=C1NC(C(CC1)N2C(C3=CC=C(NCCCCCCCCN)C=C3C2=O)=O)=O

• Molecular Weight:

  514.49

• References & Citations:

  [1]Michael Bruno Plewe, et al. Compounds and methods of treating diseases. Patent WO2022068933A1.

• Shipping Conditions:

  Blue Ice

• Clinical Information:

  No Development Reported

• CAS Number:

  2097509-49-2